Skip to content

Embecta Corp. EMBC Current ratio

Current ratio at other companies

Insulet logo
InsuletPODD
2.5×-2.0×
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
3.6×+1.3×
Medtronic logo
MedtronicMDT
2.1×+0.3×
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
3.8×+0.9×
Mannkind logo
MannkindMNKD
1.9×-0.5×
Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX
10.7×-5.2×

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity

Where this comes from

Calculated from Embecta Corp.’s reported figures.

Based on the most recent quarter.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s current ratio?
Embecta Corp. (EMBC) reported current ratio of 2.5× in Q1 2026.
How has Embecta Corp.'s current ratio changed year-over-year?
Embecta Corp.'s current ratio decreased by 0.9% year-over-year, from 2.5× to 2.5×.
What is the long-term trend for Embecta Corp.'s current ratio?
Over 4 years (2021 to 2025), Embecta Corp.'s current ratio has grown at a 7.9% compound annual growth rate (CAGR), from 1.8× to 2.4×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.